Glenmark Of India In Dispute With U.S. Partner Over HIV-Related Drug
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Pharmaceuticals called for arbitration to settle a dispute with one of its development partners, U.S.-based Napo Pharmaceuticals, over an HIV-related drug